Abbvie acquiring Pharmacyclics | Lex
Financial Times
Financial Times
  • 5 years ago
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs

US-based pharmaceuticals company AbbVie has agreed to acquire Pharmacyclics for $21bn. Lex’s Robert Armstrong and Rochelle Toplensky discuss the deal and the rising cost of doing business for Big Pharma.

► Lex: http://bit.ly/1I14JZF

► FT Markets: http://bit.ly/1J5HNd3

► Pharma: promises and paroles: http://bit.ly/1gzqEwm

Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes
Recommended
2:54
I
Up next
Financial Times Business of Football conference 2013
Financial Times
7:02
John Fallon discusses sale of Financial Times | FT Business
Financial Times
4:44
More Women Makes Business Sense - Financial Times Report
Financial Times
2:55
Tough times for US natural gas | Lex
Financial Times
3:31
Tough times at Anglo American | Lex
Financial Times
4:06
Android Phones vie for Attention - Financial Times
Financial Times
3:27
Nokia's Dramatic Profit Warning - Financial Times Analysis
Financial Times
3:22
World Economic Forum: Editor's Review - Financial Times Analysis
Financial Times
1:09
Find your next adventure at the Financial Times: My city, Nairobi
Financial Times
2:20
The Financial Times 'FT.com' Site Tour
Financial Times
4:55
Aston Martin Gets Ready To Rumble - The Financial Times
Financial Times
9:37
White House Responds To Weak Job Numbers - Financial Times
Financial Times
4:24
The Revival Of Rio De Janeiro - Financial Times
Financial Times
0:20
Financial Times Fingertips Advert - International Version
Financial Times
10:20
China's 'Shock and Awe' & the Arms War Threat - Financial Times Analysis
Financial Times
1:29
Find your next adventure at the Financial Times: My city, La Paz
Financial Times
3:34
Penjelasan proses pemilu di Indonesia oleh Financial Times
Financial Times
1:15
Haiti One Year after the Quake - Financial Times
Financial Times
3:57
UK Government Faces Tough 2011 - Financial Times Analysis
Financial Times
3:56
Aerobatics In A Pitts Special Biplane - The Financial Times
Financial Times
3:35
ImmunoGen shares are trading higher after AbbVie announced it will acquire the company in a transaction valued at $31.26 per share in cash
Benzinga
12:00
Lupin Partners With Abbvie For Oncology Drug
NDTV Profit
1:15
AbbVie Sees Increased Drug Sales
Benzinga
0:52
Earnings Recap: AbbVie, Chevron, Colgate-Palmolive, ExxonMobil, Newell
The Street
3:56
Meme-MicroVision, Twitter, Abbvie and Tech – On TheStreet Friday
The Street
0:25
Jim Cramer: AbbVie Did 'Much, Much Better Than Expected'
The Street
Financial Times
2:31
EU leaders offer the UK a six-month Brexit delay
Financial Times
1:11
ECB keeps monetary policy unchanged
Financial Times
1:59
Theresa May granted Brexit delay until end of October
Financial Times
12:28
Crunched: philanthropy versus tax avoidance
Financial Times
1:39
How scientists took first picture of a black hole
Financial Times
0:56
Theresa May arrives in Brussels seeking Brexit delay
Financial Times
Featured channels
More from
Met Office
More from
ODN
More from
SWNS
More from
GoodtoKnow
More from
Evening Standard
More from
FourFourTwo